Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties

被引:122
作者
Detheux, M
Ständker, L
Vakili, J
Münch, J
Forssmann, U
Adermann, K
Pöhlmann, S
Vassart, G
Kirchhoff, F
Parmentier, M
Forssmann, WG
机构
[1] ULB, IRIBHN, Inst Interdisciplinary Res, B-1070 Brussels, Belgium
[2] Lower Saxony Inst Peptide Res, IPF, D-30625 Hannover, Germany
[3] Euroscreen SA, B-1070 Brussels, Belgium
[4] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany
[5] Johannes Gutenberg Univ Mainz, Dept Urol, D-55131 Mainz, Germany
关键词
receptors; CCR5; chemokines; CC; biological assay; endopeptidase; HIV;
D O I
10.1084/jem.192.10.1501
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hemofiltrate CC chemokine (HCC)-1 is a recently described human chemokine that is constitutively ex-pressed in numerous tissues and is present at high concentrations in normal plasma. Using a cell line ex-pressing CC chemokine receptor (CCR)5 as a bioassay, we isolated fi-om human hemofiltrate an HCC-1 variant lacking the first eight amino acids. HCC-1[9-74] was a potent agonist of CCR1, CCR3, and CCR5 and promoted calcium flux and chemotaxis of T lymphoblasts, monocytes, and eosinophils. It also blocked entry of HIV-1 strains using CCRS as coreceptor. Limited tryptic digestion of HCC-1 generated the active variant. Conditioned media from several tumor cell lines activated HCC-1 with a high efficiency, and this activity could be inhibited by serine protease inhibitors. Our results indicate that HCC-1 represents a nonfunctional precursor that can be rapidly converted to the active chemokine by proteolytic processing. This process represents an additional mechanism by which tumor cells might generate chemoattractant molecules and recruit inflammatory cells. It might also affect HIV-1 replication in infected individuals and play an important role in AIDS pathotgenesis.
引用
收藏
页码:1501 / 1508
页数:8
相关论文
共 47 条
  • [1] Agace WW, 2000, EUR J IMMUNOL, V30, P819, DOI 10.1002/1521-4141(200003)30:3<819::AID-IMMU819>3.3.CO
  • [2] 2-P
  • [3] CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1
    Alkhatib, G
    Combadiere, C
    Broder, CC
    Feng, Y
    Kennedy, PE
    Murphy, PM
    Berger, EA
    [J]. SCIENCE, 1996, 272 (5270) : 1955 - 1958
  • [4] Human chemokines: An update
    Baggiolini, M
    Dewald, B
    Moser, B
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 675 - 705
  • [5] Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
    Berger, EA
    Murphy, PM
    Farber, JM
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 : 657 - 700
  • [6] Blanpain C, 1999, BLOOD, V94, P1899
  • [7] The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
    Bleul, CC
    Wu, LJ
    Hoxie, JA
    Springer, TA
    Mackay, CR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) : 1925 - 1930
  • [8] FORMATION OF NEUTROPHIL-ACTIVATING PEPTIDE-2 FROM PLATELET-DERIVED CONNECTIVE-TISSUE-ACTIVATING PEPTIDE-III BY DIFFERENT TISSUE PROTEINASES
    CAR, BD
    BAGGIOLINI, M
    WALZ, A
    [J]. BIOCHEMICAL JOURNAL, 1991, 275 : 581 - 584
  • [9] HIV-1 REVERSE TRANSCRIPTION - A TERMINATION STEP AT THE CENTER OF THE GENOME
    CHARNEAU, P
    MIRAMBEAU, G
    ROUX, P
    PAULOUS, S
    BUC, H
    CLAVEL, F
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1994, 241 (05) : 651 - 662
  • [10] The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
    Choe, H
    Farzan, M
    Sun, Y
    Sullivan, N
    Rollins, B
    Ponath, PD
    Wu, LJ
    Mackay, CR
    LaRosa, G
    Newman, W
    Gerard, N
    Gerard, C
    Sodroski, J
    [J]. CELL, 1996, 85 (07) : 1135 - 1148